Atlas Trials

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

Clinical trial NCT07357740 · WITHDRAWN

Trial details

NCT number
NCT07357740
Sponsor
Novo Nordisk A/S
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2026-08-27
Primary completion
2027-08-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.